HNRNPC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.660000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.658000E-01
Normal-vs-Stage2
6.022400E-01
Normal-vs-Stage3
3.324000E-01
Normal-vs-Stage4
6.547400E-01
Stage1-vs-Stage2
4.301800E-01
Stage1-vs-Stage3
6.192400E-01
Stage1-vs-Stage4
1.223210E-01
Stage2-vs-Stage3
1.959750E-01
Stage2-vs-Stage4
1.854960E-01
Stage3-vs-Stage4
1.854970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.873200E-01
Normal-vs-AfricanAmerican
5.574400E-01
Normal-vs-Asian
4.375200E-01
Caucasian-vs-AfricanAmerican
8.891400E-01
Caucasian-vs-Asian
6.819800E-01
AfricanAmerican-vs-Asian
8.769800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.344400E-01
Normal-vs-Female
4.980600E-01
Male-vs-Female
5.933800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.990600E-01
Normal-vs-Age(41-60Yrs)
9.386000E-01
Normal-vs-Age(61-80Yrs)
4.183200E-01
Normal-vs-Age(81-100Yrs)
9.278000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.264800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.973000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.660430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.498600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.728200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.544220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.197600E-01
Normal-vs-Daily Drinker
5.180000E-01
Normal-vs-Weekly Drinker
2.260200E-01
Normal-vs-Occasional Drinker
8.474200E-01
Normal-vs-Social Drinker
5.279000E-01
Non Drinker-vs-Daily Drinker
6.896400E-01
Non Drinker-vs-Weekly Drinker
7.139600E-01
Non Drinker-vs-Occasional Drinker
1.931550E-02
Non Drinker-vs-Social Drinker
3.793800E-01
Daily Drinker-vs-Weekly Drinker
5.295800E-01
Daily Drinker-vs-Occasional Drinker
1.011030E-01
Daily Drinker-vs-Social Drinker
6.964000E-01
Weekly Drinker-vs-Occasional Drinker
1.945870E-02
Weekly Drinker-vs-Social Drinker
2.456200E-01
Occasional Drinker-vs-Social Drinker
1.657180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.409600E-01
Normal-vs-Grade 2
5.625800E-01
Normal-vs-Grade 3
5.297000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.916000E-02
Grade 1-vs-Grade 3
2.996000E-02
Grade 1-vs-Grade 4
6.409600E-01
Grade 2-vs-Grade 3
3.110200E-01
Grade 2-vs-Grade 4
5.625800E-01
Grade 3-vs-Grade 4
5.297000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.392800E-01
Normal-vs-NonDiabetic
4.855800E-01
Diabetic-vs-NonDiabetic
9.005200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.284200E-01
Normal-vs-NoPancreatitis
5.544000E-01
Pancreatitis-vs-NoPancreatitis
5.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.771400E-01
Normal-vs-N1
6.083200E-01
N0-vs-N1
8.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.584200E-01
Normal-vs-TP53-NonMutant
2.508400E-01
TP53-Mutant-vs-TP53-NonMutant
1.53401999999359E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
